Form 4 · Filed Jun 18, 2026, 12:40 AM UTC
ARQT/Arcutis Biotherapeutics, Inc.
Welgus Howard G. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
8 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | S | sell | 635 | $26 | $16,300 | 37,743 |
| Jun 15, 2026 | M | other | 1,019 | $8 | $7,653 | 40,219 |
| Jun 15, 2026 | M | other | 2,255 | $9 | $19,461 | 42,474 |
| Jun 15, 2026 | S | sell | 4,096 | $24 | $99,980 | 38,378 |
| Jun 15, 2026 | M | other | 822 | — | — | 9,040 |
| Jun 15, 2026 | M | other | 1,019 | — | — | 11,201 |
| Jun 15, 2026 | M | other | 822 | $7 | $5,361 | 39,200 |
| Jun 15, 2026 | M | other | 2,255 | — | — | 24,797 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-044079